Clinical Trial

Multimodal Cardiovascular Magnetic Resonance Imaging for Cardiometabolic Pre-HF and HFpEF

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This is an observational study aiming to characterize the pathophysiological features and clinical significance of cardiometabolic early-stage heart failure using advanced multimodal cardiovascular magnetic resonance (CMR) imaging. The study will focus on patients with cardiometabolic risk factors such as diabetes, hypertension, and obesity who are in the pre-heart failure (pre-HF) stage or have heart failure with preserved ejection fraction (HFpEF). The study seeks to establish a full-chain imaging framework-from precise phenotypic classification and sensitive noninvasive diagnosis to individualized cardiovascular risk stratification. Participants will undergo multimodal CMR scans and comprehensive clinical evaluations and be followed up for primary outcome.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-03.
Trial Details
NCT Number NCT07336316
Lead Sponsor Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions Diabetes (DM), Hypertension, Heart Failure, Obesity & Overweight
Enrollment 3,000 participants
Start Date 2010-01-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-23